TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 25797308

Group type: EXPERIMENTAL
Intervention: HHP-processed mango puree (HHP-MP)
Number of subjects: 38

Group type: COMPARATOR
Intervention: Unprocessed mango puree (unprocessed-MP)
Number of subjects: 38
Study: 22897123

Group type: EXPERIMENTAL
Intervention: Mentalization-based psychotherapy (MBT) for 2 years, twice weekly, combined individual and group therapy
Number of subjects: 85

Group type: COMPARATOR
Intervention: Supportive group therapy for 2 years, biweekly
Number of subjects: 85
Study: 21295639

Group type: EXPERIMENTAL
Intervention: Patient-controlled sedation with propofol/remifentanil (PCS group)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Anesthesiologist-managed propofol sedation (propofol infusion group)
Number of subjects: 80
Study: 19826288

Group type: EXPERIMENTAL
Intervention: Leg group (10 sets of leg extension)
Number of subjects: 24
Study: 17269382

Group type: EXPERIMENTAL
Intervention: Prognostication system for risk estimation of disability occurrence
Number of subjects: 0
Study: 15687772

Group type: EXPERIMENTAL
Intervention: Closed endotracheal suction system (CES)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Open endotracheal suction system (OES)
Number of subjects: 70
Study: 11703246

Group type: EXPERIMENTAL
Intervention: Epidural patient-controlled analgesia (PCA) using pethidine (bolus 10 mg, lockout interval 10 min, 4-h maximum dose 3 mg.kg(‐1))
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intravenous patient-controlled analgesia (PCA) using pethidine (bolus 10 mg, lockout interval 10 min, 4-h maximum dose 3 mg.kg(‐1))
Number of subjects: 37

Group type: EXPERIMENTAL
Intervention: Epidural PCA
Number of subjects: 37

Group type: COMPARATOR
Intervention: Intravenous PCA
Number of subjects: 37
Study: 10322828

Group type: EXPERIMENTAL
Intervention: Zhiganle capsule (ZGLC)
Number of subjects: 146

Group type: COMPARATOR
Intervention: Dongbao Gantai (DBGT) tablets
Number of subjects: 146
Study: 8300840

Group type: EXPERIMENTAL
Intervention: Misoprostol 400 micrograms orally (up to three doses)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Gemeprost vaginal pessary 1 mg (up to five doses)
Number of subjects: 60
Study: 3488280

Group type: EXPERIMENTAL
Intervention: Physiotherapy with biofeedback
Number of subjects: 12

Group type: COMPARATOR
Intervention: Physiotherapy
Number of subjects: 12
Study: 29866947

Group type: EXPERIMENTAL
Intervention: Nivolumab
Number of subjects: 0

Group type: COMPARATOR
Intervention: Investigator's choice (IC) of chemotherapy
Number of subjects: 0
Study: 26428900

Group type: EXPERIMENTAL
Intervention: High-Velocity (HV) exercise
Number of subjects: 38

Group type: COMPARATOR
Intervention: Low-Velocity (LV) exercise
Number of subjects: 38
Study: 24836125

Group type: EXPERIMENTAL
Intervention: Simvastatin (40 mg daily)
Number of subjects: 885

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 885
Study: 22733440

Group type: EXPERIMENTAL
Intervention: Trabecular Metal Cone (TM Cone)
Number of subjects: 40

Group type: COMPARATOR
Intervention: Conventional method
Number of subjects: 40
Study: 21029638

Group type: EXPERIMENTAL
Intervention: Paliperidone extended-release tablets
Number of subjects: 81

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 81
Study: 18230966

Group type: EXPERIMENTAL
Intervention: Sibutramine 10 mg x day(-1)
Number of subjects: 15

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study: 15927974

Group type: EXPERIMENTAL
Intervention: Circumferential pulmonary vein ablation
Number of subjects: 100

Group type: COMPARATOR
Intervention: Segmental pulmonary vein ablation
Number of subjects: 100
Study: 12915747

Group type: EXPERIMENTAL
Intervention: Almitrine 100 mg per day
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Almitrine (responders subgroup)
Number of subjects: 115

Group type: EXPERIMENTAL
Intervention: Almitrine
Number of subjects: 115

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 115
Study: 11295661

Group type: EXPERIMENTAL
Intervention: Cetirizine, 0.25 mg/kg, twice daily for 18 months
Number of subjects: 817

Group type: COMPARATOR
Intervention: Placebo, matching placebo twice daily for 18 months
Number of subjects: 817
Study: 9260417

Group type: EXPERIMENTAL
Intervention: Er:YAG laser treatment for dental hard tissue
Number of subjects: 0
Study: 7684993

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy (3 courses of the 'quick' VBP scheme)
Number of subjects: 151

Group type: COMPARATOR
Intervention: Control group (no neoadjuvant chemotherapy)
Number of subjects: 151

Group type: EXPERIMENTAL
Intervention: Neoadjuvant chemotherapy
Number of subjects: 151
Study: 3563121

Group type: EXPERIMENTAL
Intervention: Mefenamic acid
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 29701042

Group type: EXPERIMENTAL
Intervention: Transcutaneous electrical acupoint stimulation (TEAS) at 2 Hz/100 Hz, 8 to 12 mA, applied at specific acupoints 30 min before anesthesia induction to the end of operation.
Number of subjects: 100

Group type: COMPARATOR
Intervention: Control group with stimulation electrode applied at corresponding points without electrical stimulation.
Number of subjects: 100
Study: 27316324

Group type: EXPERIMENTAL
Intervention: Bedtime chronotherapy with ≥1 conventional hypertension medications
Number of subjects: 0
Study: 25808497

Group type: EXPERIMENTAL
Intervention: Compression method (80-160 mL balloon volume)
Number of subjects: 88

Group type: COMPARATOR
Intervention: Standard method (50 mL balloon volume)
Number of subjects: 88
Study: 23931043

Group type: EXPERIMENTAL
Intervention: High serum magnesium concentration (1.60‐2.50 mmol/L)
Number of subjects: 162

Group type: COMPARATOR
Intervention: Normal serum magnesium concentration (0.65‐1.05 mmol/L)
Number of subjects: 162
Study: 20099160

Group type: EXPERIMENTAL
Intervention: Viable Bifidobacterium supplement
Number of subjects: 60

Group type: COMPARATOR
Intervention: Routine enteral nutrition alone (Control)
Number of subjects: 60
Study: 18996860

Group type: EXPERIMENTAL
Intervention: All‐Bran (AB)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Bran Buds with Corn (BBC)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: Bran Buds with Psyllium (BBP)
Number of subjects: 23

Group type: EXPERIMENTAL
Intervention: BBC with viscous fiber blend (VFB)
Number of subjects: 23

Group type: COMPARATOR
Intervention: Low‐fiber control
Number of subjects: 23
Study: 16796496

Group type: EXPERIMENTAL
Intervention: Telehealth intervention (experimental group, n = 10)
Number of subjects: 19

Group type: COMPARATOR
Intervention: Placebo intervention (control group, n = 9)
Number of subjects: 19
Study: 14983963

Group type: EXPERIMENTAL
Intervention: Small focus of well-differentiated carcinoma on biopsy
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Small focus of well-differentiated carcinoma on biopsy with serum PSA < 4 ng/mL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Small focus of well-differentiated carcinoma on biopsy with serum PSA >= 4 ng/mL
Number of subjects: 121

Group type: EXPERIMENTAL
Intervention: Preoperative prediction model combining biopsy results and serum PSA levels
Number of subjects: 121
Study: 10986023

Group type: EXPERIMENTAL
Intervention: Arteriography followed by carotid surgery (Group A)
Number of subjects: 186

Group type: COMPARATOR
Intervention: Carotid surgery alone (Group B)
Number of subjects: 186
Study: 8714328

Group type: EXPERIMENTAL
Intervention: PTSD assessment using Khmer translated version of the PTSD section of Diagnostic Interview Schedule for Children and Adolescents
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Depression assessment using Khmer translated version of the depression section of the Schedule for Affective Disorders and Schizophrenia for School‐Age Children‐Epidemiologic Version and the Beck Depression Inventory
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Impact of Events Scale administered to assess trauma impact
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Full PTSD syndrome assessment
Number of subjects: 99
Study: 29104028

Group type: EXPERIMENTAL
Intervention: Immersive Virtual Reality (iVR) surgical training using Oculus Rift and Leap Motion devices
Number of subjects: 95

Group type: COMPARATOR
Intervention: Standard PowerPoint presentation on a laptop
Number of subjects: 95
Study: 27191165

Group type: EXPERIMENTAL
Intervention: Deferiprone, 17 oral doses, supra-threshold concentrations (150 μM)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Deferiprone, 17 oral doses
Number of subjects: 0
Study: 25640621

Group type: EXPERIMENTAL
Intervention: Kavo PrepAssistant
Number of subjects: 76

Group type: COMPARATOR
Intervention: Classical evaluation
Number of subjects: 76
Study: 23254592

Group type: EXPERIMENTAL
Intervention: Bezafibrate (200 mg twice daily for 8 weeks)
Number of subjects: 32

Group type: COMPARATOR
Intervention: Control period
Number of subjects: 32
Study: 21364610

Group type: EXPERIMENTAL
Intervention: Hassawi rice (HR)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Uncle Ben's rice (UBR)
Number of subjects: 13
Study: 18821287

Group type: EXPERIMENTAL
Intervention: Nandrolone phenpropionate (100 mg, intramuscularly, pulse-dose)
Number of subjects: 54

Group type: COMPARATOR
Intervention: Sesame oil placebo
Number of subjects: 54
Study: 16018757

Group type: EXPERIMENTAL
Intervention: 5% sodium fluoride varnish
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Nd:YAG laser for 2 minutes
Number of subjects: 40

Group type: EXPERIMENTAL
Intervention: Combination of 5% sodium fluoride varnish and Nd:YAG laser
Number of subjects: 40

Group type: COMPARATOR
Intervention: No treatment (Control)
Number of subjects: 40
Study: 12593417

Group type: EXPERIMENTAL
Intervention: Tc‐99m HMPAO brain SPECT in children with ADHD
Number of subjects: 20
Study: 10519748

Group type: EXPERIMENTAL
Intervention: Electronic dental anesthesia
Number of subjects: 28

Group type: COMPARATOR
Intervention: Local anesthesia
Number of subjects: 28
Study: 8540731

Group type: EXPERIMENTAL
Intervention: Hotyu‐ekki‐to
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Rikkunshi‐to
Number of subjects: 8

Group type: EXPERIMENTAL
Intervention: Juzen‐taiho‐to
Number of subjects: 8

Group type: COMPARATOR
Intervention: Levofloxacin (200 mg) alone
Number of subjects: 8
Study: 1686184

Group type: EXPERIMENTAL
Intervention: 50 mg of riboflavin administered at night
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study: 7334934

Group type: COMPARATOR
Intervention: 4 mg of oestriol succinate per day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 8 mg of oestriol succinate per day
Number of subjects: 70

Group type: EXPERIMENTAL
Intervention: 16 mg of oestriol succinate per day (divided into two doses)
Number of subjects: 70
Study: 31503258

Group type: EXPERIMENTAL
Intervention: Hybrid Coronary Revascularization (HCR)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Coronary Artery Bypass Grafting (CABG)
Number of subjects: 155

Group type: EXPERIMENTAL
Intervention: Percutaneous Coronary Intervention (PTI)
Number of subjects: 155
Study: 27918928

Group type: EXPERIMENTAL
Intervention: Pre‐finishing grazing period
Number of subjects: 60

Group type: COMPARATOR
Intervention: Concentrates without grazing
Number of subjects: 60

Group type: EXPERIMENTAL
Intervention: Castration
Number of subjects: 60
Study: 25040143

Group type: EXPERIMENTAL
Intervention: Group C (pre‐emptive) received 0.125% ropivacaine 6 mL 30 min before skin incision and every 60 min during surgery, then PCEA.
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Group B (routine) was given 0.125% ropivacaine 6 mL 30 min after surgery, then PCEA.
Number of subjects: 90

Group type: COMPARATOR
Intervention: Group A (control) only received patient‐controlled epidural analgesia (PCEA).
Number of subjects: 90
Study: 24105017

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 98
Study: 21935685

Group type: EXPERIMENTAL
Intervention: Intravenous dezocine 0.1 mg/kg
Number of subjects: 120

Group type: COMPARATOR
Intervention: Placebo (0.9% saline)
Number of subjects: 120
Study: 19703068

Group type: EXPERIMENTAL
Intervention: Lidocaine 2%
Number of subjects: 49

Group type: COMPARATOR
Intervention: Placebo (N-saline)
Number of subjects: 49
Study: 17875948

Group type: EXPERIMENTAL
Intervention: Fish oil (FO) supplementation, 1 g capsule for 14 days
Number of subjects: 26

Group type: COMPARATOR
Intervention: Placebo (1 g of corn oil)
Number of subjects: 26
Study: 15136959

Group type: EXPERIMENTAL
Intervention: Telephone follow-up and counseling
Number of subjects: 34
Study: 11477047

Group type: EXPERIMENTAL
Intervention: Educational intervention through in-practice meetings discussing referrals
Number of subjects: 0
Study: 9134786

Group type: EXPERIMENTAL
Intervention: Daily ratings of IBS symptoms for 8 weeks
Number of subjects: 25

Group type: EXPERIMENTAL
Intervention: Correlation with anxiety and depression
Number of subjects: 25
Study: 8242939

Group type: EXPERIMENTAL
Intervention: Group 1 (double latex gloves)
Number of subjects: 71

Group type: EXPERIMENTAL
Intervention: Group 2 (outer orthopaedic gloves over regular latex gloves)
Number of subjects: 71

Group type: COMPARATOR
Intervention: Group 3 (Repel gloves between two regular latex gloves)
Number of subjects: 71
Study: 3295019

Group type: EXPERIMENTAL
Intervention: Oral testosterone treatment (200 mg t.i.d.)
Number of subjects: 34

Group type: COMPARATOR
Intervention: Placebo treatment
Number of subjects: 34

Group type: EXPERIMENTAL
Intervention: Ethanol consumption
Number of subjects: 34
Study: 30782866

Group type: EXPERIMENTAL
Intervention: Mat Pilates
Number of subjects: 60

Group type: COMPARATOR
Intervention: Aquatic aerobic exercises
Number of subjects: 60
Study: 28503808

Group type: EXPERIMENTAL
Intervention: Extralevator abdominoperineal excision (ELAPE)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Conventional abdominoperineal excision (CAPE)
Number of subjects: 20
Study: 26194884

Group type: EXPERIMENTAL
Intervention: rhFSH plus rhLH from stimulation day 1 (group A)
Number of subjects: 202

Group type: COMPARATOR
Intervention: rhFSH alone (days 1‐5) followed by rhFSH plus rhLH from day 6 (group B)
Number of subjects: 202
Study: 23307631

Group type: EXPERIMENTAL
Intervention: Modified Robert Jones bandage (MRJB) applied for 24 hours (Group 1)
Number of subjects: 60

Group type: COMPARATOR
Intervention: Conventional wound dressing (Group 2)
Number of subjects: 60
Study: 21593009

Group type: EXPERIMENTAL
Intervention: Participants' suggested strategies for falls prevention (n = 629)
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Exercise as a falls prevention strategy
Number of subjects: 333

Group type: EXPERIMENTAL
Intervention: Conceptualization of falls prevention
Number of subjects: 333
Study: 17433577

Group type: EXPERIMENTAL
Intervention: Prebiotic formula (0.4 g/100 ml prebiotic galacto- and long-chain fructooligosaccharides)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Standard formula (without added prebiotics)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Prebiotic formula
Number of subjects: 0
Study: 16965688

Group type: EXPERIMENTAL
Intervention: DLF regimen (n=48): 2-hour infusion of folinic acid 200 mg/m(2), followed by 5-FU bolus 400 mg/m(2) and 48-hour infusion of 5-FU 3,000 mg/m(2) every 3 weeks, combined with cisplatin 80 mg/m(2)
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: CLF regimen (n=32): 2-hour infusion of folinic acid 200 mg/m(2), followed by 5-FU bolus 400 mg/m(2) and 48-hour infusion of 5-FU 3,000 mg/m(2) every 3 weeks, combined with carboplatin AUC=5
Number of subjects: 98

Group type: EXPERIMENTAL
Intervention: DFM regimen (n=18): 2-hour infusion of folinic acid 200 mg/m(2), followed by 5-FU bolus 400 mg/m(2) on day 1-5 plus pingyangmycin 5 mg/m(2) on day 1, 3, 5
Number of subjects: 98

Group type: COMPARATOR
Intervention: Overall (all regimens)
Number of subjects: 98
Study: 12934407

Group type: EXPERIMENTAL
Intervention: Combined epidural-general anesthesia (Group A, n = 14)
Number of subjects: 42

Group type: EXPERIMENTAL
Intervention: Propofol-based total intravenous anesthesia (Group B, n = 14)
Number of subjects: 42

Group type: COMPARATOR
Intervention: Isoflurane-based inhalational-intravenous general anesthesia (Group C, n = 14)
Number of subjects: 42
Study: 10210912

Group type: EXPERIMENTAL
Intervention: nicergoline 30 mg b.i.d.
Number of subjects: 72

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 72
Study: 8726094

Group type: EXPERIMENTAL
Intervention: Beta‐adrenergic blocking agents
Number of subjects: 100

Group type: EXPERIMENTAL
Intervention: Coronary artery bypass grafting (CABG)
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patients not on beta‐blockers
Number of subjects: 100

Group type: COMPARATOR
Intervention: Patients on beta‐blockers
Number of subjects: 100
Study: 1834010

Group type: EXPERIMENTAL
Intervention: Teicoplanin (6 mg/kg once daily)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teicoplanin (30 mg/kg once daily)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Vancomycin
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Teicoplanin and vancomycin in serum ultrafiltrate and SMHB at 60 micrograms/ml
Number of subjects: 0
Study: 6309918

Group type: EXPERIMENTAL
Intervention: methylphenidate
Number of subjects: 30

Group type: COMPARATOR
Intervention: ACTH4-9 analog
Number of subjects: 30

Group type: COMPARATOR
Intervention: placebo
Number of subjects: 30
Study: 30670099

Group type: EXPERIMENTAL
Intervention: Brief Group Psychoanalytic Psychotherapy (20 weeks, weekly sessions)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Control group (waiting list)
Number of subjects: 80
Study: 31255127

Group type: EXPERIMENTAL
Intervention: Detection task with binaural streaming using frequency-proximity
Number of subjects: 19

Group type: EXPERIMENTAL
Intervention: Adding interaural delay or timbre-difference
Number of subjects: 19
Study: 28881431

Group type: EXPERIMENTAL
Intervention: SmartXide Fractional CO2 laser treatment
Number of subjects: 122
Study: 26179246

Group type: EXPERIMENTAL
Intervention: Moxifloxacin 400 mg daily for 5 days every 4 weeks
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Doxycycline 100 mg/day
Number of subjects: 99

Group type: EXPERIMENTAL
Intervention: Azithromycin 250 mg 3 times a week
Number of subjects: 99

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 99
Study: 24080932

Group type: EXPERIMENTAL
Intervention: Reversible interocclusal splint therapy (RIST)
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Self-care only
Number of subjects: 80

Group type: EXPERIMENTAL
Intervention: Activator Method Chiropractic Technique (AMCT)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Sham AMCT
Number of subjects: 80
Study: 21674396

Group type: EXPERIMENTAL
Intervention: Robot-assisted body-weight-supported treadmill training (R-T)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Unassisted body-weight-supported treadmill training (T-R)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Both types of body-weight-supported treadmill training (R-T and T-R)
Number of subjects: 13
Study: 19366448

Group type: EXPERIMENTAL
Intervention: AS-SMP three-day regimen (once daily for 3 days) (N = 476)
Number of subjects: 1384

Group type: EXPERIMENTAL
Intervention: AS-SMP 24-hour regimen (0 h, 12 h, 24 h) (N = 458)
Number of subjects: 1384

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) regular 6 doses regimen (N = 450)
Number of subjects: 1384

Group type: EXPERIMENTAL
Intervention: AS-SMP three-day regimen (once daily for 3 days)
Number of subjects: 1384

Group type: EXPERIMENTAL
Intervention: AS-SMP 24-hour regimen (0 h, 12 h, 24 h)
Number of subjects: 1384

Group type: COMPARATOR
Intervention: Artemether-lumefantrine (AL) regular 6 doses regimen
Number of subjects: 1384

Group type: EXPERIMENTAL
Intervention: AS-SMP 24-hour regimen
Number of subjects: 1384
Study: 16697153

Group type: EXPERIMENTAL
Intervention: Duloxetine 80 mg/day
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Duloxetine 120 mg/day
Number of subjects: 392

Group type: EXPERIMENTAL
Intervention: Paroxetine 20 mg/day
Number of subjects: 392

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 392
Study: 15265788

Group type: EXPERIMENTAL
Intervention: Intermediate-dose therapy (2 courses of melphalan at 100 mg/m(2) with stem cell support)
Number of subjects: 194

Group type: COMPARATOR
Intervention: Conventional chemotherapy (6 courses of oral melphalan and prednisone)
Number of subjects: 194
Study: 11297574

Group type: EXPERIMENTAL
Intervention: IGF-I treatment (15 microg/kg twice daily)
Number of subjects: 16

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: IGF-I treatment
Number of subjects: 16
Study: 9043536

Group type: EXPERIMENTAL
Intervention: 2.0 mg atropine sulfate added to the first nebulizer and saline in the second and third treatments
Number of subjects: 126

Group type: EXPERIMENTAL
Intervention: 2.0 mg atropine to the first and third treatments (with saline in the second)
Number of subjects: 126

Group type: COMPARATOR
Intervention: Saline placebo during all 3 treatments
Number of subjects: 126
Study: 8196726

Group type: EXPERIMENTAL
Intervention: Cyclosporine (4 mg per kilogram of body weight per day)
Number of subjects: 20

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20

Group type: EXPERIMENTAL
Intervention: Cyclosporine (subsequent treatment for placebo non-responders)
Number of subjects: 20
Study: 3286242

Group type: EXPERIMENTAL
Intervention: Fenugreek (15 g) soaked in water
Number of subjects: 0
Study: 29766285

Group type: EXPERIMENTAL
Intervention: Left ventricular hypertrophy (LVH)
Number of subjects: 795
Study: 27208499

Group type: EXPERIMENTAL
Intervention: Ketamine (0.8 mg/kg)
Number of subjects: 90

Group type: EXPERIMENTAL
Intervention: Subanesthetic ketamine (0.5 mg/kg) plus propofol (0.5 mg/kg)
Number of subjects: 90

Group type: COMPARATOR
Intervention: Propofol (0.8 mg/kg)
Number of subjects: 90
Study: 25106453

Group type: EXPERIMENTAL
Intervention: DA with values clarification exercise (VCE+)
Number of subjects: 135

Group type: COMPARATOR
Intervention: DA with information only (VCE-)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: DA with information plus VCE without referral (VCE+)
Number of subjects: 135

Group type: EXPERIMENTAL
Intervention: DA with information plus VCE with specific referral (VCE++)
Number of subjects: 135
Study: 24206741

Group type: EXPERIMENTAL
Intervention: Triple therapy with levofloxacin, amoxicillin, and a PPI for 10 days
Number of subjects: 81

Group type: COMPARATOR
Intervention: Triple therapy with clarithromycin for 10 days
Number of subjects: 81
Study: 21382863

Group type: EXPERIMENTAL
Intervention: Rehabilitation started within 24 hours post surgery
Number of subjects: 306
Study: 18513531

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC) 600 mg PO twice daily for a total of 14 doses (3 preoperative)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 102

Group type: EXPERIMENTAL
Intervention: N-acetylcysteine (NAC)
Number of subjects: 102